Focuses on advance of high-throughput technologies & potential of computational approaches.
Works on the identification of innovative drugs based on druggable targets & their pharmacological improvement by means of nanomedicine.
Focuses on the generation of in vitro & in vivo disease models relevant to the different RP.
OUR GROUPS
IN THIS PROGRAM
BIOENGINEERING & CELL THERAPY
Focuses on cell behaviour & tissue bioengineering
COMPUTATIONAL BIOLOGY & DATA SCIENCE
Focuses on advance of high-throughput technologies & potential of computational approaches. The aim of this transversal unit is the development of computational methods and tools to relate phenotypic and molecular characteristics in the disease groups of the scientific programmes of the CIPF.The study of sex and gender differences in these pathologies, through the massive analysis and integration of omics, clinical and imaging data, and the use of artificial intelligence methods.
DRUG DISCOVERY & NANOMEDICINE
Works on the identification of innovative drugs based on druggable targets & their pharmacological improvement by means of nanomedicine. Provides strategic technology services to design new drugs, aligning the main goals of the CIPF programs that converge to offer personalized solutions to patients based on molecular knowledge of the disease.
This occurs in the context of European standards as we are an accredited specialized screening site from the European Research infrastructure, EU OPENSCREEN.
PRECLINICAL MODELS OF DISEASE
Works on the identification of innovative drugs based on druggable targets & their pharmacological improvement by means of nanomedicine. Provides strategic technology services to design new drugs, aligning the main goals of the CIPF programs that converge to offer personalized solutions to patients based on molecular knowledge of the disease.
This occurs in the context of European standards as we are an accredited specialized screening site from the European Research infrastructure, EU OPENSCREEN.
